topotecan hydrochloride (Accord Healthcare, Inc.)


Welcome to the PulseAid listing for the topotecan hydrochloride drug offered from Accord Healthcare, Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Accord Healthcare, Inc.
NON-PROPRIETARY NAME: topotecan hydrochloride
SUBSTANCE NAME: TOPOTECAN HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-07-23
END MARKETING DATE: 0000-00-00


topotecan hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item Descriptiontopotecan hydrochloride from Accord Healthcare, Inc.
LABELER NAME: Accord Healthcare, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 4(mg/4mL)
START MARKETING DATE: 2013-07-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 16729-151_256208d7-142f-6105-e054-00144ff88e88
PRODUCT NDC: 16729-151
APPLICATION NUMBER: ANDA202351

Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare, Inc.topotecan hydrochloride
Actavis Pharma, Inc.Topotecan hydrochloride
Bedford LaboratoriesTopotecan Hydrochloride
Fresenius Kabi USA, LLCTopotecan Hydrochloride
GlaxoSmithKline LLCHYCAMTIN
Hospira, Inc.Topotecan
Ingenus Pharmaceuticals, LLCTopotecan
Mylan Institutional LLCTOPOTECAN HYDROCHLORIDE
Novartis Pharmaceuticals CorporationHYCAMTIN
Pfizer Laboratories Div Pfizer Inc.Topotecan Hydrochloride
Sagent PharmaceuticalsTopotecan Hydrochloride
Sandoz IncTopotecan
Teva Parenteral Medicines, Inc.Topotecan
Three Rivers Pharmaceuticals, LLC.Topotecan Hydrochloride